Finding treatable traits in severe asthma for personalized care
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study aims to identify specific treatable traits in people with severe asthma and build a personalized treatment plan. It will help doctors understand which treatments might work best for you based on a detailed evaluation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 79 years old
- You have had asthma for at least 6 months
- Your asthma is severe and not well controlled even with high-dose inhalers
- You are willing to undergo a thorough evaluation and follow-up for 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
This study looks at how genes are linked to different types and severities of asthma. It aims to understand why asthma affects people differently, which could lead to better treatments.
This study observes how asthma is managed and controlled in routine clinical practice. Researchers will collect information about your asthma symptoms, treatments, and outcomes over time to better understand real-world asthma management.
This trial looks at how certain proteins (Transgelin-2, Metallothionein-2, and Ezrin) are associated with asthma. It may help researchers better understand asthma biology and potentially guide future treatments.
This study tests a new way to improve care for adults with asthma who have had a recent severe attack. It aims to see if better management can prevent future flare-ups.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.